Septerna (NasdaqGM:SEPN) FY Conference Transcript

Septerna (NasdaqGM:SEPN) FY Conference March 03, 2026 03:10 PM ET Company ParticipantsJeffrey Finer - CEOJeroen Verheijen - VP and Head of Drug DiscoveryConference Call ParticipantsYaron Werber - Managing Director and Senior Biotechnology AnalystYaron WerberWelcome once again to the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst at TD Cowen, and it's a great pleasure to introduce Jeff Finer, CEO of Septerna. Septerna is really one of the preeminent GPCR drug discovery companie ...